Literature DB >> 29497991

Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.

Noemi Eiro1, Lucía González2, Anxo Martínez-Ordoñez3, Belen Fernandez-Garcia2, Luis O González2,4, Sandra Cid2, Francisco Dominguez5, Román Perez-Fernandez3, Francisco J Vizoso1,6.   

Abstract

PURPOSE: It has been reported that stromal cell features may affect the clinical outcome of breast cancer patients. Cancer associated fibroblasts (CAFs) represent one of the most abundant cell types within the breast cancer stroma. Here, we aimed to explore the influence of CAFs on breast cancer gene expression, as well as on invasion and angiogenesis.
METHODS: qRT-PCR was used to evaluate the expression of several cancer progression related genes (S100A4, TGFβ, FGF2, FGF7, PDGFA, PDGFB, VEGFA, IL-6, IL-8, uPA, MMP2, MMP9, MMP11 and TIMP1) in the human breast cancer-derived cell lines MCF-7 and MDA-MB-231, before and after co-culture with CAFs. Stromal mononuclear inflammatory cell (MIC) MMP11 expression was used to stratify primary tumors. In addition, we assessed the in vitro effects of CAFs on both MDA-MB-231 breast cancer cell invasion and endothelial cell (HUVEC) tube formation.
RESULTS: We found that the expression levels of most of the genes tested were significantly increased in both breast cancer-derived cell lines after co-culture with CAFs from either MMP11+ or MMP11- MIC tumors. IL-6 and IL-8 showed an increased expression in both cancer-derived cell lines after co-culture with CAFs from MMP11+ MIC tumors. We also found that the invasive and angiogenic capacities of, respectively, MDA-MB-231 and HUVEC cells were increased after co-culture with CAFs, especially those from MMP11+ MIC tumors.
CONCLUSIONS: Our data indicate that tumor-derived CAFs can induce up-regulation of genes involved in breast cancer progression. Our data additionally indicate that CAFs, especially those derived from MMP11+ MIC tumors, can promote breast cancer cell invasion and angiogenesis.

Entities:  

Keywords:  Angiogenesis; Breast cancer; Cancer-associated fibroblasts; MMP11; Tumor invasion

Mesh:

Substances:

Year:  2018        PMID: 29497991     DOI: 10.1007/s13402-018-0371-y

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  40 in total

1.  Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer.

Authors:  Maria Pia Protti; Lucia De Monte
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

Review 2.  Chemokines and their role in tumor growth and metastasis.

Authors:  J M Wang; X Deng; W Gong; S Su
Journal:  J Immunol Methods       Date:  1998-11-01       Impact factor: 2.303

3.  A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.

Authors:  Noemí Eiró; Belen Fernandez-Garcia; Julio Vázquez; José M Del Casar; Luis O González; Francisco J Vizoso
Journal:  Oncoimmunology       Date:  2015-01-29       Impact factor: 8.110

Review 4.  Tissue inhibitor of metalloproteinases-1 in breast cancer.

Authors:  S Ø Würtz; A-S Schrohl; N Møller Sørensen; U Lademann; I J Christensen; H Mouridsen; N Brünner
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

Review 5.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

6.  Prognostic significance of inflammatory factors expression by stroma from breast carcinomas.

Authors:  Belen Fernandez-Garcia; Noemi Eiro; Maria-Angeles Miranda; Sandra Cid; Luis O González; Francisco Domínguez; Francisco J Vizoso
Journal:  Carcinogenesis       Date:  2016-05-19       Impact factor: 4.944

7.  Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.

Authors:  Patsy S H Soon; Edward Kim; Cindy K Pon; Anthony J Gill; Katrina Moore; Andrew J Spillane; Diana E Benn; Robert C Baxter
Journal:  Endocr Relat Cancer       Date:  2013-01-07       Impact factor: 5.678

8.  Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.

Authors:  Noemi Eiró; Belen Fernandez-Garcia; Luis O González; Francisco J Vizoso
Journal:  Oncoimmunology       Date:  2013-05-01       Impact factor: 8.110

9.  The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

Authors:  P Manders; L V A M Beex; V C G Tjan-Heijnen; J Geurts-Moespot; T H Van Tienoven; J A Foekens; C G J Sweep
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

10.  Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.

Authors:  T Bachelot; I Ray-Coquard; C Menetrier-Caux; M Rastkha; A Duc; J-Y Blay
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

View more
  24 in total

1.  The role of TNF-α in chordoma progression and inflammatory pathways.

Authors:  Sukru Gulluoglu; Emre Can Tuysuz; Mesut Sahin; Cumhur Kaan Yaltirik; Aysegul Kuskucu; Ferda Ozkan; Altay Burak Dalan; Fikrettin Sahin; Ugur Ture; Omer Faruk Bayrak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-07       Impact factor: 6.730

Review 2.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

Review 3.  Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro.

Authors:  Molly M Morgan; Linda A Schuler; Jordan C Ciciliano; Brian P Johnson; Elaine T Alarid; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-03-06       Impact factor: 2.192

Review 4.  Tumor-associated macrophages: role in cancer development and therapeutic implications.

Authors:  Arash Salmaninejad; Saeed Farajzadeh Valilou; Arash Soltani; Sepideh Ahmadi; Yousef Jafari Abarghan; Rhonda J Rosengren; Amirhossein Sahebkar
Journal:  Cell Oncol (Dordr)       Date:  2019-05-29       Impact factor: 6.730

5.  Bioinformatics evaluation of a novel angiogenesis related genes-based signature for predicting prognosis and therapeutic efficacy in patients with gastric cancer.

Authors:  Ning Ma; Jie Li; Ling Lv; Chunhua Li; Kainan Li; Bin Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 6.  Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.

Authors:  Misung Park; Dohee Kim; Sunghyub Ko; Ayoung Kim; Kyumin Mo; Hyunho Yoon
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

Review 7.  Targeting of the tumor immune microenvironment by metformin.

Authors:  Zihong Wu; Caidie Zhang; Masoud Najafi
Journal:  J Cell Commun Signal       Date:  2021-10-05       Impact factor: 5.908

Review 8.  The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches.

Authors:  Daniel Cruceriu; Oana Baldasici; Ovidiu Balacescu; Ioana Berindan-Neagoe
Journal:  Cell Oncol (Dordr)       Date:  2020-01-03       Impact factor: 6.730

Review 9.  HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer.

Authors:  Kim Jun Cheng; Mohammed Abdullah Alshawsh; Elsa Haniffah Mejia Mohamed; Surendran Thavagnanam; Ajantha Sinniah; Zaridatul Aini Ibrahim
Journal:  Cell Oncol (Dordr)       Date:  2019-11-01       Impact factor: 6.730

Review 10.  Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Alicja Forma; Amr Maani; Elżbieta Sitarz; Mansur Rahnama-Hezavah; Elżbieta Radzikowska; Piero Portincasa
Journal:  Cells       Date:  2020-04-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.